Reduction of intraoperative EEG burst suppression - test of efficacy
Not Applicable
Recruiting
- Conditions
- R94.0Abnormal results of function studies of central nervous system
- Registration Number
- DRKS00015839
- Lead Sponsor
- Klinikum rechts der Isar der Technische Universität München - Klinik für Anästhesiologie und Intensivmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Age = 60 years, Surgical interventions in general anesthesia (volatile or total intravenous anesthesia), expected surgery duration = 1h, ASA 1-4, written informed consent prior to study participation
Exclusion Criteria
Neurological or psychiatric disorders, hearing difficulty, deafness, neurosurgical (intra)cranial surgery, pregnancy, expected continuous mandatory ventilation after surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie burst suppression reduction in DRKS00015839 EEG anesthesia study?
How does BsR intervention compare to standard anesthetic protocols in reducing intraoperative burst suppression?
Are there specific biomarkers that predict response to burst suppression reduction during general anesthesia?
What adverse events are associated with burst suppression modulation in DRKS00015839 and how are they managed?
What combination therapies or alternative approaches show promise for managing R94.0 EEG abnormalities in surgical settings?